ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
50 hedge funds and large institutions have $100M invested in Alpine Immune Sciences, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
$1.66M |
| 2 |
Axa
Paris,
France
|
$5.3M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
$1.79M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
$1.04M |
| 5 |
O
OrbiMed
New York
|
$480K |
